Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pharmabiz
57m
Bristol Myers Squibb, 2seventy bio to discontinue enrollment in phase 3 KarMMa-9 study of Abecma in patients with newly diagnosed MM
Bristol Myers Squibb, 2seventy bio to discontinue enrollment in phase 3 KarMMa-9 study of Abecma in patients with newly diagnosed MM: Princeton, New Jersey Friday, September 27, 2 ...
35m
on MSN
Bristol-Myers wins FDA nod for first-of-its-kind antipsychotic
The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Promotes watch collection
World's oldest cheese found
Producing doc on Diddy
Ending password-sharing
50/50 ball ownership suit
Urgent safety alert for 737s
Boxes to distribute Narcan
US sanctions crypto network
Targeted Black residents?
Stadiums to serve as shelters
Chinese submarine sank
Kotb leaving 'Today'
More executives leave
On Secret Service failures
NC board removes 747K
WI duplicate ballot flap
NIH finds misconduct
Military recruiting rebounds
To withdraw sickle cell drug
Settles defamation lawsuit
Capital goods orders up
Arrives in Luxembourg
Weekly jobless claims fall
Rose announces retirement
US economy grew
Jan. 6 report delayed
US suicides steady, high
RU hits Ukraine's power grid
Related topics
Abecma
Bristol-Myers Squibb
Phase 3 KarMMa-9
TSVT
Feedback